New York Approves AssureRx's Lab | GenomeWeb

The story has been corrected to say that certification from New York is for AssureRx's laboratory not its GeneSightRx test.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The New York State Department of Health has certified AssureRx's laboratory, allowing residents in the state access to the company's pharmacogenomic test, GeneSightRx.

As a result of the approval, the Mason, Ohio-based company's laboratory is certified to analyze DNA samples for pharmacogenomic testing in all 50 states.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.